Israel’s Taliaz (reported here previously) has just received a $2.7 million grant from the European Union’s Horizon 2020 program. It will help Taliaz expand its clinical research using its PREDICTIX products to help psychiatrists treat and manage patient depression in EU countries.
https://www.calcalistech.com/ctech/articles/0,7340,L-3870692,00.html